Monday, July 17, 2017
4:37:29 PM ET
As security concerns grow in a world of cloud-powered and OTT-to-any-screen video services, service providers are taking the necessary steps to protect their digital services spanning Internet, video and mobile from piracy, hacks and illegal activity.
4:08:28 PM ET
Thanks to rail technology leader Bombardier Transportation, travel in Kuala Lumpur is now faster and more efficient. With the entry into service of the BOMBARDIER CITYFLO 650 rail control solution on the new second phase of Klang Valley Mass Rapid Transits (KVMRT) Sungai Buloh-Kajang (SBK) Line 1, passengers in the capital will enjoy a fast and safe ride over the …
4:00:45 PM ET
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that OCREVUS® (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS), marking the second approval of OCREVUS for both indications following the FDA decision in the US in March …
3:53:26 PM ET
Bayer and the White Ribbon Alliance (WRA) announce that two-years into their partnership and less than one year from community project launch, their Every Woman Every Child commitment to empower women to practice self-care has reached 1,200 women in 91 communities across four developing countries.
3:43:03 PM ET
Nico started the race from P5 on his qualifying Supersoft Pirelli tyres, changing to a new set of Soft tyres on lap 24. He lost a place to Valtteri Bottas in the opening laps but thereafter continued to pull away from both Force Indias.
3:38:22 PM ET
Novartis, a global leader in Immunology & Dermatology, confirmed today positive 5 year efficacy and safety results for Cosentyx® from a Phase III long-term extension study in patients with moderate-to-severe plaque psoriasis.